A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes
<p>Abstract</p> <p>Background</p> <p>Subjects with type 2 diabetes are at an increased risk of vascular complications. The use of carotid ultrasound remains an attractive, non-invasive method to monitor atherosclerotic disease progression and/or response to treatment in...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-06-01
|
Series: | Cardiovascular Ultrasound |
Online Access: | http://www.cardiovascularultrasound.com/content/3/1/15 |
id |
doaj-14b7ddcbcde8464b8f3beb4ff15aafaa |
---|---|
record_format |
Article |
spelling |
doaj-14b7ddcbcde8464b8f3beb4ff15aafaa2020-11-24T23:17:02ZengBMCCardiovascular Ultrasound1476-71202005-06-01311510.1186/1476-7120-3-15A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetesZinman BernardHanley Anthony JGFenster AaronHouse Andrew ASpence J DavidPollex Rebecca LHarris Stewart BHegele Robert A<p>Abstract</p> <p>Background</p> <p>Subjects with type 2 diabetes are at an increased risk of vascular complications. The use of carotid ultrasound remains an attractive, non-invasive method to monitor atherosclerotic disease progression and/or response to treatment in patients with type 2 diabetes, with intima-media thickness routinely used as the gold standard to detect pathology. However, alternative measurements, such as plaque area or volume, may represent a potentially more powerful approach. Thus, the objective of this study was to compare the traditional intima-media thickness measurement against the novel total plaque volume measurement in analyzing carotid atherosclerosis development in individuals with type 2 diabetes.</p> <p>Methods</p> <p>The case-control study included 49 Oji-Cree adults with diabetes or impaired glucose tolerance, aged 21–69, and 49 sex- and age-matched normoglycemic subjects. At baseline, metabolic variables were measured, including body mass index, waist circumference, total cholesterol:high density lipoprotein ratio, plasma triglycerides, plasma glucose, and serum insulin. Carotid ultrasound measurements, 7 years later, assessed carotid arterial intima-media thickness and total plaque volume.</p> <p>Results</p> <p>At baseline, the two groups were well matched for smoking habits, hypertension, body mass index, and waist circumference. Differences were noted in baseline measurements of total cholesterol:high density lipoprotein (<it>P </it>= 0.0006), plasma triglycerides (<it>P </it>< 0.0001) and fasting glucose (<it>P </it>< 0.0001). After seven years, carotid ultrasound scans revealed that total plaque volume measurements (<it>P </it>= 0.037), but not intima-media thickness measurements, were higher in subjects with diabetes/impaired glucose tolerance compared to the normoglycemic controls. Correlation between intima-media thickness and total plaque volume was moderate. Based on our study findings, to achieve power levels >0.70 when comparing intima-media thickness measurements for diabetics versus non-diabetics, thousands of study subjects are required. For comparing total plaque volume measurements, only hundreds of study subjects are required.</p> <p>Conclusion</p> <p>The development of atherosclerotic plaque is greater in subjects with diabetes/impaired glucose tolerance. Total plaque volume appears to capture the atherosclerotic disease burden more effectively in subjects with type 2 diabetes, and would be an appropriate outcome measure for studies aimed at changing the diabetic milieu.</p> http://www.cardiovascularultrasound.com/content/3/1/15 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zinman Bernard Hanley Anthony JG Fenster Aaron House Andrew A Spence J David Pollex Rebecca L Harris Stewart B Hegele Robert A |
spellingShingle |
Zinman Bernard Hanley Anthony JG Fenster Aaron House Andrew A Spence J David Pollex Rebecca L Harris Stewart B Hegele Robert A A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes Cardiovascular Ultrasound |
author_facet |
Zinman Bernard Hanley Anthony JG Fenster Aaron House Andrew A Spence J David Pollex Rebecca L Harris Stewart B Hegele Robert A |
author_sort |
Zinman Bernard |
title |
A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes |
title_short |
A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes |
title_full |
A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes |
title_fullStr |
A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes |
title_full_unstemmed |
A comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes |
title_sort |
comparison of ultrasound measurements to assess carotid atherosclerosis development in subjects with and without type 2 diabetes |
publisher |
BMC |
series |
Cardiovascular Ultrasound |
issn |
1476-7120 |
publishDate |
2005-06-01 |
description |
<p>Abstract</p> <p>Background</p> <p>Subjects with type 2 diabetes are at an increased risk of vascular complications. The use of carotid ultrasound remains an attractive, non-invasive method to monitor atherosclerotic disease progression and/or response to treatment in patients with type 2 diabetes, with intima-media thickness routinely used as the gold standard to detect pathology. However, alternative measurements, such as plaque area or volume, may represent a potentially more powerful approach. Thus, the objective of this study was to compare the traditional intima-media thickness measurement against the novel total plaque volume measurement in analyzing carotid atherosclerosis development in individuals with type 2 diabetes.</p> <p>Methods</p> <p>The case-control study included 49 Oji-Cree adults with diabetes or impaired glucose tolerance, aged 21–69, and 49 sex- and age-matched normoglycemic subjects. At baseline, metabolic variables were measured, including body mass index, waist circumference, total cholesterol:high density lipoprotein ratio, plasma triglycerides, plasma glucose, and serum insulin. Carotid ultrasound measurements, 7 years later, assessed carotid arterial intima-media thickness and total plaque volume.</p> <p>Results</p> <p>At baseline, the two groups were well matched for smoking habits, hypertension, body mass index, and waist circumference. Differences were noted in baseline measurements of total cholesterol:high density lipoprotein (<it>P </it>= 0.0006), plasma triglycerides (<it>P </it>< 0.0001) and fasting glucose (<it>P </it>< 0.0001). After seven years, carotid ultrasound scans revealed that total plaque volume measurements (<it>P </it>= 0.037), but not intima-media thickness measurements, were higher in subjects with diabetes/impaired glucose tolerance compared to the normoglycemic controls. Correlation between intima-media thickness and total plaque volume was moderate. Based on our study findings, to achieve power levels >0.70 when comparing intima-media thickness measurements for diabetics versus non-diabetics, thousands of study subjects are required. For comparing total plaque volume measurements, only hundreds of study subjects are required.</p> <p>Conclusion</p> <p>The development of atherosclerotic plaque is greater in subjects with diabetes/impaired glucose tolerance. Total plaque volume appears to capture the atherosclerotic disease burden more effectively in subjects with type 2 diabetes, and would be an appropriate outcome measure for studies aimed at changing the diabetic milieu.</p> |
url |
http://www.cardiovascularultrasound.com/content/3/1/15 |
work_keys_str_mv |
AT zinmanbernard acomparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT hanleyanthonyjg acomparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT fensteraaron acomparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT houseandrewa acomparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT spencejdavid acomparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT pollexrebeccal acomparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT harrisstewartb acomparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT hegeleroberta acomparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT zinmanbernard comparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT hanleyanthonyjg comparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT fensteraaron comparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT houseandrewa comparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT spencejdavid comparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT pollexrebeccal comparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT harrisstewartb comparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes AT hegeleroberta comparisonofultrasoundmeasurementstoassesscarotidatherosclerosisdevelopmentinsubjectswithandwithouttype2diabetes |
_version_ |
1725585141145796608 |